NAMS Certification Exam 2025/2026
Early Menopause
FMP before age 45
Late Menopause
FMP after age 54
Bilateral oophorectomy prior to age forty five will increase risks for:
- All cause mortality
- Coronary coronary heart disease
- CVD
- Menopause signs
- Worsening temper symptoms
- Higher incidence of Parkinson Disease
- Associated with cognitive impairment
Early Menopause Transition (-2)
7 or greater days continual distinction in cycle length from preceding ordinary cycle
- Results of multiplied follicular ageing and depletion
- Inhibin B decreases
- FSH increases (Variable)
LOOP Cycles
Explains elevation of Estradiol in perimenopause
- Rising FSH degrees recruit second follicle throughout luteal segment which results in
overproduction of Estradiol
- This reasons menstrual modifications in future cycles
Decreased AMH in Early Menopause Transition
More frequent anovulatory cycles
Decreased Inhibin B in Early Menopause Transition
- Skipped menstrual cycles
- Mastalgia
, - Migraine
- Menorrhagia (with LOOP cycles)
- Endometrial Hyperplasia
Late Menopause Transition (-1)
60 or greater days of amenorrhea for women elderly forty five years or older
- Women forty-forty four years with recurrent episodes of amenorrhea of 60 day for longer within
a yr improves prediction of access into late menopause transition
Late Menopause Transition (-1) Duration
1-three years
Late Menopause Transition (-1) Symptoms
VMS probably
STRAW Stage where FSH > 25
Late Menopause Transition (-1)
Elevated FSH symptoms in Late Menopause Transition
- VMS
- Sleep disturbance
- Changes in weight distribution
- Increased variability in cycle period
Decreased Inhibin B in Late Menopause Transition
- Mood modifications
- Cognitive court cases
- Changes in sexual functioning
- Increased prevalence of anovulation
Decreased AMH in Late Menopause Transition
- GSM
- Bone loss
- CVD troubles
- Interval of amenorrhea > 60 days
Early Menopause
FMP before age 45
Late Menopause
FMP after age 54
Bilateral oophorectomy prior to age forty five will increase risks for:
- All cause mortality
- Coronary coronary heart disease
- CVD
- Menopause signs
- Worsening temper symptoms
- Higher incidence of Parkinson Disease
- Associated with cognitive impairment
Early Menopause Transition (-2)
7 or greater days continual distinction in cycle length from preceding ordinary cycle
- Results of multiplied follicular ageing and depletion
- Inhibin B decreases
- FSH increases (Variable)
LOOP Cycles
Explains elevation of Estradiol in perimenopause
- Rising FSH degrees recruit second follicle throughout luteal segment which results in
overproduction of Estradiol
- This reasons menstrual modifications in future cycles
Decreased AMH in Early Menopause Transition
More frequent anovulatory cycles
Decreased Inhibin B in Early Menopause Transition
- Skipped menstrual cycles
- Mastalgia
, - Migraine
- Menorrhagia (with LOOP cycles)
- Endometrial Hyperplasia
Late Menopause Transition (-1)
60 or greater days of amenorrhea for women elderly forty five years or older
- Women forty-forty four years with recurrent episodes of amenorrhea of 60 day for longer within
a yr improves prediction of access into late menopause transition
Late Menopause Transition (-1) Duration
1-three years
Late Menopause Transition (-1) Symptoms
VMS probably
STRAW Stage where FSH > 25
Late Menopause Transition (-1)
Elevated FSH symptoms in Late Menopause Transition
- VMS
- Sleep disturbance
- Changes in weight distribution
- Increased variability in cycle period
Decreased Inhibin B in Late Menopause Transition
- Mood modifications
- Cognitive court cases
- Changes in sexual functioning
- Increased prevalence of anovulation
Decreased AMH in Late Menopause Transition
- GSM
- Bone loss
- CVD troubles
- Interval of amenorrhea > 60 days
